UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061308
Receipt number R000070150
Scientific Title An empirical study on improving the readability and searchability of package inserts for over-the-counter drugs through generative AI support
Date of disclosure of the study information 2026/04/20
Last modified on 2026/04/19 10:07:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An empirical study on improving the readability and searchability of package inserts for over-the-counter drugs through generative AI support

Acronym

GAI-OTC Read/Search Study

Scientific Title

An empirical study on improving the readability and searchability of package inserts for over-the-counter drugs through generative AI support

Scientific Title:Acronym

GAI-OTC Read/Search Study

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In addition to the attached document, generative AI shall be utilized as an auxiliary information-provision tool, and its impact, through interactive information presentation, on consumers' level of understanding and behavioral choices, as well as the inherent risks, shall be examined empirically.

Basic objectives2

Others

Basic objectives -Others

The level of understanding regarding the descriptions in the attached document.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The level of understanding regarding the descriptions in the attached document.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

Participants shall be randomly allocated into two groups. Group A (the generative AI-assisted group) shall view the existing OTC drug package insert (Appendix 1) while receiving support from generative AI (Notebook LM) and respond to the questions.

Interventions/Control_2

Group B (the control group) shall respond to the questions while referring to the same package insert as Group A, without using generative AI.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Individuals aged 18 years or older.
(2) Individuals who have provided written consent to participate in this study based on their own free will.

Key exclusion criteria

(1) Individuals who have difficulty reading Japanese text.
(2) Individuals who are medical professionals, such as physicians, dentists, nurses, physical therapists, registered dietitians, pharmacists, etc.; students of medical faculties or departments; registered sales clerks; and veterinarians.
(3) Individuals who have used ibuprofen within the six months preceding the date of the interview survey.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Tohru
Middle name
Last name Aomori

Organization

Takasaki University of Health and Welfare

Division name

Faculty of Pharmacy

Zip code

370-0033

Address

60 Nakaorui-machi, Takasaki-shi, Gunma, Japan

TEL

027-352-1180

Email

aomori-t@takasaki-u.ac.jp


Public contact

Name of contact person

1st name Tohru
Middle name
Last name Aomori

Organization

Takasaki University of Health and Welfare

Division name

Faculty of Pharmacy

Zip code

370-0033

Address

60 Nakaorui-machi, Takasaki-shi, Gunma, Japan

TEL

027-352-1180

Homepage URL


Email

aomori-t@takasaki-u.ac.jp


Sponsor or person

Institute

Takasaki University of Health and Welfare

Institute

Department

Personal name

Tohru Aomori


Funding Source

Organization

Takasaki University of Health and Welfare

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Takasaki University of Health and Welfare

Address

60 Nakaorui-machi, Takasaki-shi, Gunma, Japan

Tel

027-352-1180

Email

aomori-t@takasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 04 Month 06 Day

Date of IRB

2026 Year 04 Month 06 Day

Anticipated trial start date

2026 Year 04 Month 23 Day

Last follow-up date

2026 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 04 Month 19 Day

Last modified on

2026 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070150